Copyright Reports & Markets. All rights reserved.

Global Spinal Muscular Atrophy Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Spinal Muscular Atrophy Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Spinal Muscular Atrophy Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Early Stage Candidates
    • 1.4.3 Late Stage Candidates
  • 1.5 Market by Application
    • 1.5.1 Global Spinal Muscular Atrophy Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital
    • 1.5.3 Clinic
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Spinal Muscular Atrophy Market Perspective (2015-2026)
  • 2.2 Global Spinal Muscular Atrophy Growth Trends by Regions
    • 2.2.1 Spinal Muscular Atrophy Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Spinal Muscular Atrophy Historic Market Share by Regions (2015-2020)
    • 2.2.3 Spinal Muscular Atrophy Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Spinal Muscular Atrophy Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Spinal Muscular Atrophy Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Spinal Muscular Atrophy Players by Market Size
    • 3.1.1 Global Top Spinal Muscular Atrophy Players by Revenue (2015-2020)
    • 3.1.2 Global Spinal Muscular Atrophy Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Spinal Muscular Atrophy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Spinal Muscular Atrophy Market Concentration Ratio
    • 3.2.1 Global Spinal Muscular Atrophy Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy Revenue in 2019
  • 3.3 Spinal Muscular Atrophy Key Players Head office and Area Served
  • 3.4 Key Players Spinal Muscular Atrophy Product Solution and Service
  • 3.5 Date of Enter into Spinal Muscular Atrophy Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Spinal Muscular Atrophy Historic Market Size by Type (2015-2020)
  • 4.2 Global Spinal Muscular Atrophy Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Spinal Muscular Atrophy Market Size by Application (2015-2020)
  • 5.2 Global Spinal Muscular Atrophy Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Spinal Muscular Atrophy Market Size (2015-2020)
  • 6.2 Spinal Muscular Atrophy Key Players in North America (2019-2020)
  • 6.3 North America Spinal Muscular Atrophy Market Size by Type (2015-2020)
  • 6.4 North America Spinal Muscular Atrophy Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Spinal Muscular Atrophy Market Size (2015-2020)
  • 7.2 Spinal Muscular Atrophy Key Players in Europe (2019-2020)
  • 7.3 Europe Spinal Muscular Atrophy Market Size by Type (2015-2020)
  • 7.4 Europe Spinal Muscular Atrophy Market Size by Application (2015-2020)

8 China

  • 8.1 China Spinal Muscular Atrophy Market Size (2015-2020)
  • 8.2 Spinal Muscular Atrophy Key Players in China (2019-2020)
  • 8.3 China Spinal Muscular Atrophy Market Size by Type (2015-2020)
  • 8.4 China Spinal Muscular Atrophy Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Spinal Muscular Atrophy Market Size (2015-2020)
  • 9.2 Spinal Muscular Atrophy Key Players in Japan (2019-2020)
  • 9.3 Japan Spinal Muscular Atrophy Market Size by Type (2015-2020)
  • 9.4 Japan Spinal Muscular Atrophy Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Spinal Muscular Atrophy Market Size (2015-2020)
  • 10.2 Spinal Muscular Atrophy Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Spinal Muscular Atrophy Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Spinal Muscular Atrophy Market Size by Application (2015-2020)

11 India

  • 11.1 India Spinal Muscular Atrophy Market Size (2015-2020)
  • 11.2 Spinal Muscular Atrophy Key Players in India (2019-2020)
  • 11.3 India Spinal Muscular Atrophy Market Size by Type (2015-2020)
  • 11.4 India Spinal Muscular Atrophy Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Spinal Muscular Atrophy Market Size (2015-2020)
  • 12.2 Spinal Muscular Atrophy Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Spinal Muscular Atrophy Market Size by Type (2015-2020)
  • 12.4 Central & South America Spinal Muscular Atrophy Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Lonis Pharmaceuticals
    • 13.1.1 Lonis Pharmaceuticals Company Details
    • 13.1.2 Lonis Pharmaceuticals Business Overview
    • 13.1.3 Lonis Pharmaceuticals Spinal Muscular Atrophy Introduction
    • 13.1.4 Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2015-2020))
    • 13.1.5 Lonis Pharmaceuticals Recent Development
  • 13.2 F. Hoffmann-La Roche
    • 13.2.1 F. Hoffmann-La Roche Company Details
    • 13.2.2 F. Hoffmann-La Roche Business Overview
    • 13.2.3 F. Hoffmann-La Roche Spinal Muscular Atrophy Introduction
    • 13.2.4 F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2015-2020)
    • 13.2.5 F. Hoffmann-La Roche Recent Development
  • 13.3 AveXis
    • 13.3.1 AveXis Company Details
    • 13.3.2 AveXis Business Overview
    • 13.3.3 AveXis Spinal Muscular Atrophy Introduction
    • 13.3.4 AveXis Revenue in Spinal Muscular Atrophy Business (2015-2020)
    • 13.3.5 AveXis Recent Development
  • 13.4 Novartis
    • 13.4.1 Novartis Company Details
    • 13.4.2 Novartis Business Overview
    • 13.4.3 Novartis Spinal Muscular Atrophy Introduction
    • 13.4.4 Novartis Revenue in Spinal Muscular Atrophy Business (2015-2020)
    • 13.4.5 Novartis Recent Development
  • 13.5 Cytokinetics
    • 13.5.1 Cytokinetics Company Details
    • 13.5.2 Cytokinetics Business Overview
    • 13.5.3 Cytokinetics Spinal Muscular Atrophy Introduction
    • 13.5.4 Cytokinetics Revenue in Spinal Muscular Atrophy Business (2015-2020)
    • 13.5.5 Cytokinetics Recent Development
  • 13.6 Ionis Pharmaceuticals
    • 13.6.1 Ionis Pharmaceuticals Company Details
    • 13.6.2 Ionis Pharmaceuticals Business Overview
    • 13.6.3 Ionis Pharmaceuticals Spinal Muscular Atrophy Introduction
    • 13.6.4 Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2015-2020)
    • 13.6.5 Ionis Pharmaceuticals Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Spinal Muscular Atrophy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Spinal Muscular Atrophy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Lonis Pharmaceuticals
    F. Hoffmann-La Roche
    AveXis
    Novartis
    Cytokinetics
    Ionis Pharmaceuticals
    ...

    Market segment by Type, the product can be split into
    Early Stage Candidates
    Late Stage Candidates
    Market segment by Application, split into
    Hospital
    Clinic
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now